Episode 183: Proton-pump inhibitors – the evidence for the good and the bad
In episode 183, the Mikes and James shine a bright light on the evidence around the use of proton pump inhibitors. We look at the good and bad outcomes and realize it is all about the numbers and the quality of the evidence. After 45 minutes the bright light and our knowledge starts to dim until we get to the end of the podcast when we shut the light off completely.
Show notes
1) Benefit of PPIs versus H2RA and placebo
Acute
Cochrane Library CD003244
Chronic http://www.cks.nhs.uk/dyspepsia_proven_gord/evidence/supporting_evidence/no_response_to_initial_therapy/extending_treatment_duration#-330424
2) Prevention of NSAID –induced endoscopic ulcers
Cochrane Library CD002296
3) Stress ulcers
Crit Care Med 2010;38:1-7
4) Rebound
Gastroenterology 2009;137:80-7
5) Withdrawal
Gastroenterology 2001;121:1095–1100
Aliment Pharmacol Ther 2007;25:709–714
6) On demand use
Am J Gastroenterol 2007;102:642–653
7) Esomeprazole
Clin Gastro Hepat 2006;4:1452–8
8) Interactions
BMJ 2012;345:e4388 doi: 10.1136/bmj.e4388
9) Fractures
Drugs 2012;72:437-45
10) Pneumonia
Cleveland Clinic J Med 2011;78:39-49
11) C. difficile
Dig Dis Sci 2011;56:931–50
12) Iron and B12, and cancer
Dig Dis Sci 2011;56:931–50
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!